Transaction overview
AMETEK, Inc., an American industrial technology company, has acquired a portfolio of instrumentation businesses from CD&R (Carlyle Digital and Risk). The deal is valued at $5 billion in cash and was completed on July 1, 2026. Indicor Instrumentation, the target asset, comprises several companies that design and manufacture mission-critical solutions for demanding industrial and scientific applications. With annual sales of approximately $1.1 billion, this acquisition significantly strengthens AMETEK's position in specialized instrumentation markets.
Deal structure and financing
The transaction was primarily financed through a combination of debt and equity issuance, though specific details on the exact split have not been disclosed at this time. Citigroup Global Markets Inc., Jefferies, and Goldman Sachs were involved as lead banks for the acquisition financing. AMETEK has committed to maintaining certain financial metrics post-acquisition to ensure the portfolio's stability and growth potential, but precise leverage ratios are yet to be announced.
AMETEK did not disclose any specific lock-up agreements or IPO optionality tied to this deal. However, it is known that CD&R retained no stake in the acquired businesses after closing, indicating a full divestiture of their holdings.
Strategic context
This acquisition aligns with AMETEK's strategic focus on expanding its footprint in high-growth industrial and scientific markets through targeted M&A activity. By acquiring Indicor Instrumentation, AMETEK aims to leverage CD&R’s portfolio management expertise while enhancing its own technological capabilities and market presence. The deal also enables CD&R to realize a substantial return on their 2022 investment in the unit, which they had been positioning for an exit since early 2023.
Historically, Indicor has been a significant contributor to CD&R's growth, with its performance exceeding expectations in several key sectors. AMETEK’s decision reflects a strategic shift towards more specialized offerings within their core industrial technology segments, thereby strengthening competitive barriers and operational efficiency.
Regulatory path
The acquisition was reviewed by regulatory bodies in the United States and Europe due to the multinational nature of both parties involved. The Hart-Scott-Rodino Antitrust Improvements Act (HSR) filing was submitted in early 2026, with a corresponding European Union merger notification following shortly thereafter.
No specific remedies were required from either party as part of the regulatory approval process. The deal's timeline adhered to standard antitrust review procedures, culminating in unconditional clearance from both jurisdictions by mid-2026.